Patent · US Active

Compositions including triciribine and trastuzumab and methods of use thereof

US9186403B2 · kind B2 · utility

0Cited by

24References

13Claims

0Family size

Assignee

University of South Florida · US

Inventors

Jin Q. Cheng · Tampa, US
Said M. Sebti · Tampa, US

Key dates

Filing date	Nov 26, 2013
Grant date	Nov 17, 2015
Priority date	—
Expiry date	Nov 26, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/73
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to combination therapies including triciribine and related compounds and trastuzumab or a salt thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.